Kexim supports Celltrion's US production facility M&A
The Export-Import Bank of Korea has announced financing worth KRW350 billion ($238 million) for Celltrion’s acquisition of Eli Lilly’s production facilities in the US. The transaction is intended to support South Korean biopharmaceutical company Celltrion’s establishment of an...